Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Enliven Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- −6 vs. Q3 2025
- Shares held
- 62.4M
- +3.00M (+5.0%) vs. Q3 2025
- Total value
- $960.9M
- −$254.7M (−21.0%) vs. Q3 2025
- New holders
- 20
- 46 more added
- Sold out
- 26
- 45 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 371,906 | $5.73M | 0.01% | +31,424+9.2% | Added |
| Dimensional Fund Advisors LP | 398,893 | $6.14M | 0.00% | +238,434+148.6% | Added |
| Morgan Stanley | 411,823 | $6.34M | 0.00% | +153,439+59.4% | Added |
| Spruce Street Capital LP | 446,084 | $6.87M | 2.27% | +446,084 | New |
| Candriam Luxembourg S.C.A. | 453,019 | $6.98M | 0.03% | −156,333−25.7% | Reduced |
| 5AM Venture Management, LLC | 772,477 | $11.9M | 3.74% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 798,405 | $12.3M | 0.63% | +112,298+16.4% | Added |
| Blackstone Group Inc. | 954,946 | $14.7M | 0.06% | −365,646−27.7% | Reduced |
| Soleus Capital Management, L.P. | 1,025,000 | $15.8M | 0.67% | +1,025,000 | New |
| Geode Capital Management, LLC | 1,048,722 | $16.2M | 0.00% | −36,291−3.3% | Reduced |
| State Street Corp | 1,052,862 | $16.2M | 0.00% | +87,725+9.1% | Added |
| Pictet Asset Management Holding SA | 1,303,235 | $20.1M | 0.02% | −94,852−6.8% | Reduced |
| Capital Research Global Investors | 1,304,346 | $20.1M | 0.00% | −11,119−0.8% | Reduced |
| Citadel Advisors LLC | 1,424,344 | $21.9M | 0.01% | +263,841+22.7% | Added |
| Novo Holdings A/S | 1,480,000 | $22.8M | 1.77% | +53,740+3.8% | Added |
| Point72 Asset Management, L.P. | 1,504,601 | $23.2M | 0.04% | +464,191+44.6% | Added |
| Janus Henderson Group PLC | 1,671,724 | $25.7M | 0.01% | −121,859−6.8% | Reduced |
| Vanguard Group Inc | 2,801,665 | $43.1M | 0.00% | +248,651+9.7% | Added |
| VR Adviser, LLC | 3,226,331 | $49.7M | 2.45% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 3,513,680 | $54.1M | 0.25% | +418,673+13.5% | Added |
| BlackRock, Inc. | 3,613,326 | $55.6M | 0.00% | +94,802+2.7% | Added |
| Fairmount Funds Management LLC | 3,711,444 | $57.2M | 4.35% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 3,830,000 | $59.0M | 2.16% | +2,670,000+230.2% | Added |
| Commodore Capital LP | 4,692,809 | $72.3M | 4.81% | 00.0% | Unchanged |
| FMR LLC | 7,107,635 | $109.5M | 0.01% | −21,561−0.3% | Reduced |
| OrbiMed Advisors LLC | 7,959,538 | $122.6M | 2.51% | 00.0% | Unchanged |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −947,405−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −783,411−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −156,463−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −73,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −59,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −50,492−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −40,314−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −40,314−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −31,438−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −27,518−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −16,458−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −13,371−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −13,097−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −10,811−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −10,675−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −3,181−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −491−100.0% | Sold out |
| ORG Partners LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |